drugset

drugset / Trial / NCT00466791

Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

NCT00466791 ↗

Phase 2 Completed 93 enrolled Noven Therapeutics

RandomizedCrossoverTriple-blindTreatment

Summary

Evaluate the behavioral effects of MTS in children aged 6-12 with ADHD

Timeline

Start: 2004-08
Primary completion: 2005-05
Completion: 2005-05

Publications

Results McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Atten Disord. 2006 Feb;9(3):476-85. doi: 10.1177/1087054705284089.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Methylphenidate	Small molecule	27.5 mg	Other
Comparator	Methylphenidate	Small molecule	41.3 mg	Other
Comparator	Methylphenidate	Small molecule	55 mg	Other
Comparator	Methylphenidate	Small molecule	82.5 mg	Other

Indications